JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8642 R547
2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK1/2/4 inhibitor,ATP-competitive

Soluble in DMSO
B3277 AMG 925

Target: Cyclin-Dependent Kinases|FLT3

Summary: FLT3/CDK4 inhibitor,potent and selective

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
B4754 LDC000067
2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK9 inhibitor, novel and highly specific

insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
A8885 Ro 3306
4 Citation

Target: Cyclin-Dependent Kinases

Summary: An ATP-competitive, potent CDK1 inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
A8736 THZ531

Target: Cyclin-Dependent Kinases

Summary: CDK12 and CDK13 covalent inhibitor

≥55.8 mg/mL
A8882 THZ1
12 Citation

Target: Cyclin-Dependent Kinases

Summary: Covalent CDK7 inhibitor,potent and selective

≥28.3 mg/mL
B4736 THZ1 Hydrochloride

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor

≥30.13 mg/mL
B6935 Aminopurvalanol A

Target: Cyclin-Dependent Kinases

Summary: cyclin-dependent kinase inhibitor

Soluble in DMSO